| Cat. No. |
Product Name |
Information |
| PC-49722 |
RAD140
AR agonist
|
Vosilasarm (RAD-140) is a potent, orally bioavailable, nonsteroidal selective androgen receptor modulator (SARM), shows excellent affinity for the androgen receptor (Ki=7 nM). |
| PC-49412 |
EPI-7170
AR-NTD inhibitor
|
EPI-7170 is a potent next-generation analog of Ralaniten (EPI-002) and inhibitor of androgen receptor N-terminal domain (AR-NTD), inhibits androgen-induced PSA-luciferase activity in transiently transfected LNCaP cells with IC50 of 1.08 uM. |
| PC-38370 |
Rezvilutamide
Androgen Receptor inhibitor
|
Rezvilutamide (SHR3680) is a novel and pure androgen-receptor (AR) antagonist that shows potent antitumor activity against castration-resistant prostate cancer (CRPC) but with much less brain distribution than enzalutamide. |
| PC-73372 |
A4B17
BAG1L-AR NTD inhibitor
|
A4B17 is a small molecule that inhibits BAG1L-AR NTD interaction, inhibits the proliferation of AR positive prostate cancer cells. |
| PC-73220 |
Pyrilutamide
AR antagonist
|
Pyrilutamide (KX826) is an androgen receptor (AR) antagonist and a potential first-in-class topical drug for the treatment of androgenetic alopecia (AGA) and acne vulgaris. |
| PC-72512 |
JNJ-pan-AR
AR inhibitor
|
JNJ-pan-AR is a highly potent, selective antagonist of androgen receptor (AR) wild-type and F877L mutant for the treatment of the F877L mutant and wild-type CRPC. |
| PC-35497 |
Leelamine hydrochloride
|
Leelamine hydrochloride (Dehydroabietylamine) is a novel inhibitor of androgen receptor (AR), inhibits castration-resistant prostate cancer cells. |
| PC-45933 |
N-desmethyl Enzalutamide
|
Amajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.. |
| PC-45255 |
Boldenone undecylenate
|
A synthetic, anabolic-androgenic steroid (AAS) and androgen ester that is used in veterinary medicine, a long-acting ester of boldenone.. |
